HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

AMPA-induced excitotoxic lesions of the basal forebrain: a significant role for the cortical cholinergic system in attentional function.

Abstract
The aim of the present study was to clarify the role of the basal forebrain (BF)-cortical cholinergic system in visual attentional function by investigating the effect of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)-induced lesions of the basal forebrain on performance of a five-choice serial reaction time task. AMPA lesions in the present study produced a profound effect on performance of the task, as measured by choice accuracy and correct response latency. This deficit was significantly greater than that observed in earlier studies following ibotenate- or quisqualate-induced lesions of the BF. However, detailed histological and biochemical analysis revealed three rather different BF lesions depending upon the batch of AMPA supplied. In one group of animals (BF/1) the deficits in task performance were substantially greater and longer lasting compared to another group of lesioned animals (BF/2), which showed behavioral recovery several months following the lesion. The former sustained severe pallidal damage in addition to marked reductions in cortical ChAT activity. Support for the attentional nature of these deficits was obtained by the ability to improve task performance in BF/1 lesioned animals by increasing the duration of the visual stimulus and thus reducing the attentional load placed on these animals. In contrast, performance deficits could be reinstated in those animals showing behavioral recovery (BF/2) by reducing the duration of the visual stimulus and thus increasing attentional load. In the second experiment more discrete lesions of the magnocellular cholinergic neurons were made, resulting in extensive reduction of cortical ChAT activity with considerably less neuronal loss from the dorsal pallidum compared to the BF/1 lesion group. Once again, deficits on the task were substantially greater than observed previously following either quisqualate- or ibotenate-induced BF lesions. Furthermore, the cholinergic specificity of these deficits was supported by the attenuation of behavioral impairments following administration of the anti-cholinesterase physostigmine. Taken together with our earlier work, which has failed to demonstrate mnemonic deficits following lesions to the magnocellular neurons of the nucleus basalis of Meynert, these results suggest that the most consistent deficit produced following lesions of the BF-cortical cholinergic system is attentional dysfunction Analogous deficits in visual attention are also seen in patients with Alzheimer's disease, which can also be improved by anti-cholinesterase treatment.
AuthorsJ L Muir, B J Everitt, T W Robbins
JournalThe Journal of neuroscience : the official journal of the Society for Neuroscience (J Neurosci) Vol. 14 Issue 4 Pg. 2313-26 (Apr 1994) ISSN: 0270-6474 [Print] United States
PMID7512637 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Neurotoxins
  • alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
  • Physostigmine
  • Choline O-Acetyltransferase
Topics
  • Analysis of Variance
  • Animals
  • Attention (drug effects)
  • Cerebral Cortex (drug effects, enzymology, physiology)
  • Choline O-Acetyltransferase (metabolism)
  • Conditioning, Psychological
  • Frontal Lobe (enzymology, physiology)
  • Male
  • Neurotoxins (toxicity)
  • Organ Specificity
  • Physostigmine (pharmacology)
  • Prosencephalon (drug effects, pathology, physiology)
  • Rats
  • Rats, Inbred Strains
  • Reaction Time (drug effects)
  • alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: